| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 10/12/2004 | US6802813 Methods and apparatus for monitoring and quantifying the movement of fluid |
| 10/07/2004 | WO2004084817A2 Siderophore conjugates of photoactive dyes for photodynamic therapy |
| 10/07/2004 | WO2004004757A8 Treatment for eye disorder |
| 10/07/2004 | US20040198783 Targeted bone marrow protection agents |
| 10/07/2004 | US20040198638 Administering docetaxel or paclitaxel derivative conjugated to polyglutamic acid, polyaspartic acid, or polylysine as antitumor or anticarcinogenic agent; radiation; autoimmune disorders, rheumatoid arthritis; coatings of stents for prevention of restenosis |
| 10/07/2004 | US20040197336 Antitumor, anticarcinogenic agents |
| 10/07/2004 | US20040197335 Non-myeloablative tolerogenic treatment with tyrphostins |
| 10/07/2004 | DE10312659A1 New 5-aminolevulinic acid derivatives useful for photodynamic tumor therapy and/or diagnosis |
| 10/06/2004 | EP1464338A1 Particle with a membrane |
| 10/06/2004 | CN1169580C 166 Ho-DTPA, its preparing method and application as liquid radiation source |
| 10/05/2004 | US6800086 Reduced fluence rate PDT |
| 09/30/2004 | WO2004083392A2 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
| 09/30/2004 | WO2004082579A2 Nemorubicin as radiosensitizer in combination with radiation therapy against tumors |
| 09/30/2004 | WO2004030661A3 Therapeutic compositions comprising a boron-containing compound |
| 09/30/2004 | WO2004012667A3 Photoactivated anti-viral and anti-cancer agent |
| 09/30/2004 | US20040192900 Calicheamicin derivative-carrier conjugates |
| 09/30/2004 | US20040192670 For inhibiting bone resorption, treating/preventing osteoporosis, and inhibiting vascular restenosis, diabetic retinopathy, macular degeneration, aniogenesis, atherosclerosis, arthritis, tumor growth and metastasis |
| 09/30/2004 | US20040192665 Mesoporphyrin IX covalently linked to doxorubicin; anticarcinogenic, antiproliferative, and antitumor agents; side effect reduction |
| 09/30/2004 | US20040192639 administering a tumor sensitizing agent comprising 5-chloro-2'-deoxycytidine, 4-N-methyl 5-fluoro-2'-deoxycytidine (FdC) and a cytidine deaminase inhibitor (tetrahydrouridine or Zebularine) then subjecting tumor to radiation; composition with the agent and the inhibitor |
| 09/30/2004 | US20040191278 Enhancing dermal collagen production; wrinkle treatment; vasodilation with nicotinic acid and irradiation |
| 09/30/2004 | US20040191249 Exposing tumor to ionizing radiation; administering drug library; isolating binding drug; cancer diagnosis; drug screening |
| 09/30/2004 | US20040191168 Tumor cell killing by cell cycle checkpoint abrogation combined with Inhibition of the classical mitogen activated protein (map) kinase pathway |
| 09/30/2004 | CA2519289A1 Nemorubicin as radiosensitizer in combination with radiation therapy against tumors |
| 09/30/2004 | CA2519084A1 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
| 09/29/2004 | EP1037531B1 Method of treatment of pigmented cancer cells utilizing photodynamic therapy |
| 09/29/2004 | EP0912196B1 Use of a thexaphyrin in the preparation of a medicament for use with a chemotherapeutic agent in cancer chemosensitization |
| 09/29/2004 | EP0804238B1 Method to prevent transplant rejection |
| 09/29/2004 | EP0616508B2 Gas filled liposomes and their use as ultrasonic contrast agents |
| 09/29/2004 | CN1533271A 5-amino levulic acid as photosensitizer in ligh chemical therapy and cpmbination of its ester and another photosensitizer, and their use in therapy |
| 09/28/2004 | US6797257 Suitable for use as a contrast agent with a plurality of imaging modalities, including, for example, ultrasound, magnetic resonance imaging, and computed temography; neutron capture therapy |
| 09/23/2004 | WO2004081014A1 Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof |
| 09/23/2004 | WO2004080483A1 Targeted agents for both photodiagnosis and photodynamic therapy |
| 09/23/2004 | WO2004080284A2 Antibody-targeted photodynamic therapy |
| 09/23/2004 | WO2004024877A3 Human kininogen d3 domain polypeptide as an anti-angiogenic and anti-tumor agent |
| 09/23/2004 | US20040186087 Siderophore conjugates of photoactive dyes for photodynamic therapy |
| 09/23/2004 | US20040186082 Applying a vitamin D precursors followed by exposure to ultraviolet radiation or blue light; calcitriol and calcitriol analog precursors, NFkappaB inhibitors, vitamin D receptor stimulants and/or photosensitizers |
| 09/23/2004 | US20040185564 Biodegradable copolymer and nucleic acid delivery system |
| 09/23/2004 | CA2530166A1 Antibody-targeted photodynamic therapy |
| 09/23/2004 | CA2523605A1 Targeted agents for both photodiagnosis and photodynamic therapy |
| 09/22/2004 | EP1459738A1 Pharmaceutical composition having thrombolytic, anti-inflammatory and cytoprotective properties |
| 09/22/2004 | EP1458417A1 Method for inactivating bacteria and leukocytes in thrombocyte suspensions |
| 09/22/2004 | CN1531442A Perylenequinones for use as photosensitizers and sonosensitizers |
| 09/21/2004 | US6794505 Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy |
| 09/21/2004 | US6794376 Delivering a therapeutic agent to said tissue; delivering a permeabilizer to the tissue; and elevating the temperature of the tissue to above normal body temperature. |
| 09/21/2004 | US6793933 Dietary supplements for enhancing the immune system |
| 09/16/2004 | WO2004078174A1 Resonance modulator for diagnosis and therapy |
| 09/16/2004 | WO2004013180A3 Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof |
| 09/16/2004 | WO2003065971A3 Non-myeloablative tolerogenic treatment with tyrphostins |
| 09/16/2004 | US20040181114 Methods of enhancing radiation effects with metal nanoparticles |
| 09/16/2004 | US20040180872 Method for the preparation of selectively-substituted corroles and new substituted corroles |
| 09/16/2004 | US20040180864 Novel aromatic azides for type I phototherapy |
| 09/16/2004 | US20040180856 Aqueous solution including partially methylated cyclodextrin |
| 09/16/2004 | US20040180812 Methods of treating and preventing proliferative disease |
| 09/16/2004 | US20040180096 Ceramic based nanoparticles for entrapping therapeutic agents for photodynamic therapy and method of using same |
| 09/16/2004 | US20040180057 Neutron capture therapy |
| 09/16/2004 | CA2517355A1 Resonance modulator for diagnosis and therapy |
| 09/15/2004 | EP1456359A2 Preparation of vaccines using photosensitizer and light |
| 09/15/2004 | EP1305317B1 Dihydroporphyrin derivatives and their uses |
| 09/15/2004 | EP0979104B1 Sonodynamic therapy using an ultrasound sensitizer compound |
| 09/14/2004 | US6790827 Bioconjugates and delivery of bioactive agents |
| 09/10/2004 | WO2004075819A2 Activation and production of radiolabeled particles |
| 09/10/2004 | CA2519349A1 Activation and production of radiolabeled particles |
| 09/09/2004 | US20040176473 Methods for delivering compounds into a cell |
| 09/09/2004 | US20040176345 Administering a quenching photosensitizer molecule for side effect reduction to retinal pigmented epithelium; age related macular degeneration |
| 09/09/2004 | US20040176343 Platinum amine glycine complex derivatives; antiproliferative and antitumor agents; side effect reduction; reversibly active; on and off |
| 09/09/2004 | US20040176290 Anti-angiogenic state in mice and humans with retinal photorecptor cell degeneration |
| 09/09/2004 | US20040176282 Cellular delivery and activation of polypeptide-nucleic acid complexes |
| 09/09/2004 | US20040176277 Methods of treating Pin1 associated disorders |
| 09/09/2004 | US20040175368 Use of crystal violet as photochemotherapeutic agent |
| 09/08/2004 | EP1454137A2 Use of a labeled ligand having human cd4 specificity for producing a diagnostic used in the analysis of migration and/or distribution patterns of cell populations |
| 09/08/2004 | EP1453546A2 Treatment of angiogenesis disorders using targeted nanoparticles |
| 09/08/2004 | EP1453431A2 Method and apparatus for the stimulation of hair growth |
| 09/08/2004 | EP0893989B1 Compounds combining allopathic substances with corresponding homeopathic substances |
| 09/08/2004 | EP0763009B1 Photocleavable conjugates for the detection and isolation of biomolecules |
| 09/02/2004 | WO2004074190A1 Magnetic fluid treatment device and uses thereof |
| 09/02/2004 | WO2003086312A3 Conjugates comprising cancer cell specific ligands, a sugar and cancer chemotherapeutic agents/boron neutron capture therapy agents, and uses thereof |
| 09/02/2004 | US20040171602 involve modifying the apical ligands associated with the central metal component of metallotexaphyrins; Changing the pharmacokinetics and/or the biodistribution of the complex in this fashion may result in, for example, better clearance |
| 09/02/2004 | US20040171601 Photodynamic and sonodynamic therapy |
| 09/02/2004 | US20040170603 Using radiolabeled annexin; radiotherapy for tumors |
| 09/01/2004 | EP1452185A1 Activation and production of radiolabeled particles |
| 09/01/2004 | EP1451300A2 Methods and compositions for the use of stromal cells to support embryonic and adult stem cells |
| 09/01/2004 | EP1450790A2 Photosensitizing carbamate derivatives |
| 09/01/2004 | EP1450774A2 Chlorin photosensitizing agents for use in photodynamic therapy |
| 08/26/2004 | WO2004071579A2 Photodynamic therapy for the treatment of prostatic conditions |
| 08/26/2004 | WO2004071435A2 Enhanced Bioavailability Using Laser Resonant Homogenization |
| 08/26/2004 | WO2004071386A2 Compositions comprising microcapsules containing magnetic nanoparticles and biologically active molecules, their preparation and use |
| 08/26/2004 | WO2004026111B1 Flexible and/or elastic brachytherapy seed or strand |
| 08/26/2004 | WO2003103585A3 Methods of treating angiogenesis, tumor growth, and metastasis |
| 08/26/2004 | CA2515733A1 Photodynamic therapy for the treatment of prostatic conditions |
| 08/26/2004 | CA2515407A1 Enhanced bioavailability of nutrients, pharmaceutical agents, and other bioactive substances through laser resonant homogenization or modification of molecular shape or crystalline form |
| 08/25/2004 | EP1448101A2 Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility |
| 08/25/2004 | EP1083881B1 LIPOSOME COMPOSITIONs containing a quinolone derivative AND their use as antibacterial agents |
| 08/25/2004 | EP1082138B1 Texaphyrin conjugates and uses thereof |
| 08/19/2004 | WO2004069326A2 Light probe for ultraviolet light activated gene transduction |
| 08/19/2004 | WO2004069281A1 Bifunctional molecules comprising at least one integrin-binding and their use in imaging and therapy of angiogenesis and related disorders |
| 08/19/2004 | WO2004069273A1 Use of a porphyrin compound fro the treatment of skin fungi |
| 08/19/2004 | WO2004069209A2 Compositions and methods for increasing the sensitivity of apoptosis-resistant tumor cells to inducers of apoptosis |
| 08/19/2004 | WO2004034876A3 Magnetically guided particles for radiative therapies |
| 08/19/2004 | US20040162240 Cobalamin conjugates useful as antitumor agents |
| 08/19/2004 | US20040161430 Dye-azide compounds for dual phototherapy |